1. 1100 Limiting factors to appropriate follow-up in cervical cancer screening. (September 2015) Authors: Viguier, J.; Eisinger, F.; Cortot, A.; Touboul, C.; Blay, J.Y.; Greillier, L.; Couraud, S.; Lhomel, C.; Morére, J.F.; Pivot, X. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1101 Less cancer screening in the vulnerable population? Results from the EDIFICE 4 survey. (September 2015) Authors: Morere, J.F.; Viguier, J.; Greillier, L.; Touboul, C.; Blay, J.Y.; Couraud, S.; Cortot, A.; Lhomel, C.; Pivot, X.; Eisinger, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1208 Being cured: What it means and what it takes. (September 2015) Authors: Eisinger, F.; Pivot, X.; Viguier, J.; Touboul, C.; Blay, J.Y.; Cortot, A.; Greillier, L.; Lhomel, C.; Couraud, S.; Morére, J.F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1209 Lung cancer screening: Who should pay? Results from a nationwide survey. (September 2015) Authors: Cortot, A.; Greillier, L.; Morere, J.F.; Touboul, C.; Pivot, X.; Eisinger, F.; Jean-Yves, B.; Lhomel, C.; Viguier, J.; Couraud, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1320 Eribulin mesylate in metastatic breast cancer, a focus on safety and efficacy in elderly patients. Results from the EVHALAVEN multicentric retrospective cohort. (September 2015) Authors: Martin-babau, J.; Robert, M.; Septans, A.L.; Paillard, M.J.; Pivot, X.; Soibinet, P.; Gourmelon, C.; Brunot, A.; Lefeuvre-plesse, C.; Korenbaum, C.; Petit, T.; Marquis, A.; Bourgeois, H.; Uwer, L.; Som, M.; Desclos, H.; Campone, M.; Campion, L.; Tredan, O.; Patsouris, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 1865 Activity and toxicity profile of eribulin mesylate in heavily pretreated metastatic breast cancer: An observational study (EVHALAVEN). (September 2015) Authors: Patsouris, A.; Septans, A.L.; Paillard, M.J.; Pivot, X.; Soibinet, P.; Jovenin, N.; Robert, M.; Gourmelon, C.; Korembaum, C.; Petit, T.; Martin-babau, J.; Brunot, A.; Lefeuvre-plesse, C.; Adele, M.; Bourgeois, H.; Som, M.; Uwer, L.; Campone, M.; Campion, L.; Tredan, O. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 1945 Phase III HannaH study of subcutaneous or intravenous trastuzumab for HER2-positive early breast cancer: Exploratory subgroup analyses of pathological complete response and 3-year event-free survival according to body weight and anti-drug antibody status. (September 2015) Authors: Jackisch, C.; Hegg, R.; Stroyakovskiy, D.; Ahn, J.S.; Melichar, B.; Chen, S.C.; Crepelle-Fléchais, A.; Lauer, S.; Shing, M.; Pivot, X. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 1956 Safety and tolerability of subcutaneous trastuzumab for HER2-positive early breast cancer in patients with lower body weight and in Asian patients: SafeHer Phase III study subgroup analyses. (September 2015) Authors: Jung, K.H.; Ataseven, B.; Verrill, M.; De Laurentiis, M.; Azim, H.A.; Pivot, X.; Al-Sakaff, N.; Lauer, S.; Shing, M.; Gligorov, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 284PReal-life study of BRCA genetic screening in metastatic breast cancer. (18th September 2017) Authors: Meynard, G.; Villanueva, C.; Thiery-Vuillemin, A.; Mansi, L.; Montcuquet, P.; Meneveau, N.; Chaigneau, L.; Bazan, F.; Almotlak, H.; Dobi, E.; Nguyen Tan Hon, T.; Klajer, E.; Fagnoni-Legat, C.; Paget-Bailly, S.; Meurisse, A.; Collonge-Rame, M-A.; Populaire-Ventron, C.; Pivot, X.; Curtit, E. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 3-year follow-up of a phase III study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in HER2 positive early or locally advanced breast cancer in neoadjuvant setting. (March 2019) Authors: Pivot, X.; Bondarenko, I.; Dvorkin, M.; Sarosiek, T.; Wojtukiewicz, M.; Shparyk, Y.; Kim, Y.; Lim, J. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗